Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.
| Employees | 29 (15 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
Looking for a particular Infinitopes employee's phone or email?
Jo Brewer is the CSO and Interim COO of Infinitopes.
15 people are employed at Infinitopes.